Clinical Trial: Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

Study Status: Terminated
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

Brief Summary: The purpose of this study is to find if Etanercept can improve the outcome of ocular lesions of Behcet's Disease treated with Methotrexate and Prednisolone

Detailed Summary: To test in a randomized single blind control trial the efficacy of Etanercept in patients with posterior uveitis and/or retinal vasculitis of Behcet's disease treated with Methotrexate and prednisolone
Sponsor: Tehran University of Medical Sciences

Current Primary Outcome: Visual Acuity, Disease Activity Index (DAI) for Posterior Uveitis, DAI for Retinal vasculitis [ Time Frame: One Year ]

Original Primary Outcome: Same as current

Current Secondary Outcome: DAI for Anterior Uveitis, Total Inflammatory Acitivity Index, Total Adjusted Disease Activity Index [ Time Frame: One Year ]

Original Secondary Outcome: Same as current

Information By: Tehran University of Medical Sciences

Dates:
Date Received: June 30, 2009
Date Started: October 2010
Date Completion: October 2013
Last Updated: November 19, 2010
Last Verified: November 2010